President-elect Donald Trump's second term could shake things up for Big Law firms in Washington, D.C., with firm leaders anticipating big changes in their regulatory practices.

Partners say they expect certain practices to benefit from Trump's regulatory agenda, such as international trade, antitrust, tax and national security. At the same time, some areas may see a slowdown, such as Food and Drug Administration and renewable practices.